Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients

NCT01503905 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Nos Premenopausal

Interventions

DRUG: Docetaxel
DRUG: epirubicin
DRUG: cyclophosphamide
PROCEDURE: Modified radical mastectomy or breast-conserving Surgery
DRUG: Docetaxel (post-operative)
DRUG: Epirubicin (post-operative)
DRUG: Cyclophosphamide (post-operative)
RADIATION: Radiation therapy
DRUG: Herceptin （post-operative)
DRUG: Tamoxifen (post-operative)

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University